These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Implications of the urokinase study concerning the surgical treatment of pulmonary embolism. Sautter RD; Myers WO; Wenzel FJ J Thorac Cardiovasc Surg; 1972 Jan; 63(1):54-9. PubMed ID: 5008120 [No Abstract] [Full Text] [Related]
3. A national cooperative trial of thrombolysis in pulmonary embolism: phase I results of urokinase therapy. Sasahara AA; Sharma GV; McIntyre KM; Belko JS; Hyers TM J La State Med Soc; 1972 Apr; 124(4):130-6. PubMed ID: 5018733 [No Abstract] [Full Text] [Related]
16. Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent. Sasahara AA; Cannilla JE; Belko JS; Morse RL; Criss AJ N Engl J Med; 1967 Nov; 277(22):1168-73. PubMed ID: 6058604 [No Abstract] [Full Text] [Related]
17. Treatment of pulmonary embolism with urokinase. Results of clinical trial (phase 1). Hyers TM; Stengle JM; Sherry S Circulation; 1970 Dec; 42(6):979-80. PubMed ID: 5492546 [No Abstract] [Full Text] [Related]
18. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Wan S; Quinlan DJ; Agnelli G; Eikelboom JW Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836 [TBL] [Abstract][Full Text] [Related]
19. The use of fibrinolytic agents. Sasahara AA; Wall RT; Harburg CB West J Med; 1981 Feb; 134(2):128-33. PubMed ID: 7222662 [No Abstract] [Full Text] [Related]
20. The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Marder VJ Ann Intern Med; 1979 May; 90(5):802-8. PubMed ID: 434689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]